DSM (DSM) Stock Price & Analysis
DSM (DSM) rose 0.66% to USD 6.13 as of June 10, 2026 at 00:52 UTC, according to Nexqual real-time market data.
DSM last closed at USD 6.09; the session ranged USD 6.09–6.13 on volume of 62,728 shares. Market capitalization is $303.00M, with a 52-week range of USD 5.45–6.3 (NYQ). Source: Nexqual, June 10, 2026 at 00:52 UTC.
Key Statistics (as of June 10, 2026 at 00:52 UTC)
| Price | USD 6.13 |
|---|---|
| Change | ▲ 0.66% (up) |
| Previous Close | USD 6.09 |
| Open | USD 6.09 |
| Day Range | USD 6.09 – 6.13 |
| 52-Week Range | USD 5.45 – 6.3 |
| Volume | 62,728 shares |
| Market Cap | $303.00M |
| Exchange | NYQ |
Technical Analysis (DSM)
Nexqual's technical model rates DSM "STRONG BUY" based on 5 bullish and 0 bearish signals across 124 daily candles, as of June 10, 2026 at 00:52 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 57.42 (neutral) |
| vs SMA50 | Above (USD 6.07) |
| MACD | 0.01 (positive) |
Analyst Ratings (DSM)
Wall Street analysts rate DSM "None", per Nexqual as of June 10, 2026 at 00:52 UTC.
| Consensus Rating | None |
|---|
Earnings (DSM)
Source: Nexqual, June 10, 2026 at 00:52 UTC.
Financials & Fundamentals (DSM)
| Total Revenue | $22.76M |
|---|---|
| Revenue Growth (YoY) | +1.50% |
| Gross Margin | +100.00% |
| Operating Margin | +87.77% |
| Profit Margin | -24.23% |
| ROE | -1.66% |
| Debt / Equity | 36.39 |
| Current Ratio | 0.15 |
| Total Cash | $681,411 |
| Total Debt | $117.84M |
| Free Cash Flow | $7.05M |
Source: Nexqual, June 10, 2026 at 00:52 UTC.
Financial Health Score (DSM)
Nexqual rates DSM's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 00:52 UTC.
| Growth | Mixed — Revenue +1.5% YoY (latest Q), slow |
|---|---|
| Profitability | Weak — Small revenue base — building scale |
| Balance Sheet | Mixed — $681K cash vs $118M debt |
| Cash Flow | Strong — FCF $7M, 31% margin |
| Efficiency | Critical — ROE -2%, ROA 2.5% |
Ownership (DSM)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +60.97% |
| Shares Outstanding | 49.43M |
| Short % of Float | +0.23% |
Source: Nexqual, June 10, 2026 at 00:52 UTC.
Major Backers & Investors (DSM)
Notable institutional backers of DSM include Saba Capital Management, L.P., Bulldog Investors, LLP, Pathstone Holdings, LLC, according to Nexqual as of June 10, 2026 at 00:52 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Saba Capital Management, L.P. | 10.48% |
| Bulldog Investors, LLP | 6.83% |
| Pathstone Holdings, LLC | 6.47% |
| SIT Investment Associates Inc | 4.27% |
| RiverNorth Capital Management, LLC | 3.36% |
| Special Opportunities Fund, Inc. | 3% |
| High Income Securities Fund | 2.65% |
| Guggenheim Capital, LLC | 2.07% |
Source: Nexqual, June 10, 2026 at 00:52 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| LEO | Dreyfus Strategic Municipals, I | USD 6.43 | ▲ 0.94% |
| CXE | MFS High Income Municipal Trust | USD 3.65 | ▲ 0% |
| MFM | MFS Municipal Income Trust | USD 5.38 | ▲ 0.19% |
| PMM | Putnam Managed Municipal Income | USD 6.23 | ▲ 0.16% |
| CXH | MFS Investment Grade Municipal | USD 7.63 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:52 UTC. This page is informational and not investment advice.